IP Library Granted Patent US 11,207,477
Granted Patent B2
US 11,207,477 · App. 16/613,578 · Granted Dec 28, 2021

Formulation and aerosol canisters, inhalers, and the like containing the formulation

Inventor: Peter D. Hodson (Derbyshire, GB)
Assignee: Kindeva Drug Delivery L.P.
A61M15/009A61K9/124A61K31/137A61K31/46A61K47/06A61K47/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,207,477
App. No.
16/613,578
Granted
Dec 28, 2021
Kind
B2
Abstract

Formulations containing pharmaceutical active agent, propellant, and water at least partially adsorbed on or absorbed within one or more nylon pellets or nylon components of, for example, an inhaler such as a metered dose inhaler. Canisters, typically sealed canisters, containing such formulations. Inhalers, such as metered dose inhalers, containing such canisters. Methods of making and using the same.

Claims (13)

1. A method of making an aerosol composition,

the method comprising:

forming a composition, the composition comprising a liquid comprising a propellant, the propellant comprising one or more of HFA- 134 a and HFA- 227 , and one or more pharmaceutical active agents dissolved or dispersed in the liquid, wherein the one or more pharmaceutical active agents is a hydrate,

soaking one or more nylon pellets in water to form one or more water soaked nylon pellets, wherein at least some of the water is adsorbed on or absorbed within the one or more water soaked nylon pellets,

removing at least some water from a surface of the one or more water soaked nylon pellets, and

adding the one or more water soaked nylon pellets obtained from the removing step to the composition to form the aerosol composition.

2. The method of claim 1 , wherein at least one of the one or more pharmaceutical active agents is a hydrate of ipratropium or a hydrate of an ipratropium salt.

3. The method of claim 1 , wherein at least one of the one or more pharmaceutical active agents is ipratropium bromide monohydrate.

4. The method of claim 1 , wherein the composition further comprises albuterol.

5. The method of claim 1 , wherein the nylon is nylon 6,6.

6. The method of claim 1 , wherein the propellant comprises HFA- 134 a.

7. The method of claim 1 , wherein at least some of the water is dissolved or dispersed in the liquid and the concentration of the water dissolved or dispersed in the liquid is between 50 ppm and 500 ppm based on the liquid and any components dissolved or dispersed in the liquid.

8. The method of claim 1 , wherein the step of removing at least some water is accomplished by blotting the water soaked nylon pellets.

Assignments (5)
SECURITY INTEREST Recorded Dec 14, 2022
From: KINDEVA DRUG DELIVERY L.P.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 062122/0618 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT R/F 053586/0715 Recorded Dec 12, 2022
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 062115/0707 →
SECURITY INTEREST Recorded Aug 24, 2020
From: KINDEVA DRUG DELIVERY L.P.
To: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
Reel/Frame 053586/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2020
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 052818/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2019
From: HODSON, PETER D.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 051008/0857 →